Immediate Impact
38 standout
Citing Papers
Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes
2025 Standout
Glioblastoma vaccines: past, present, and opportunities
2024 Standout
Works of R.-D. Kortmann being referenced
NOA-08 randomized phase III trial of 1-week-on/1-week-off temozolomide versus involved-field radiotherapy in elderly (older than age 65) patients with newly diagnosed anaplastic astrocytoma or glioblastoma (Methusalem).
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| R.-D. Kortmann | 167 | 86 | 82 | 105 | 15 | 235 | |
| Helen Benghiat | 130 | 82 | 55 | 90 | 16 | 212 | |
| N. Hashimoto | 93 | 82 | 62 | 79 | 16 | 246 | |
| Lauren T. Thornton | 186 | 196 | 37 | 79 | 12 | 300 | |
| Carmel Loughrey | 87 | 55 | 63 | 45 | 15 | 191 | |
| Jean Philippe Maire | 137 | 107 | 28 | 55 | 10 | 221 | |
| Molly Hemenway | 145 | 67 | 38 | 69 | 23 | 250 | |
| Daniel Czerný | 75 | 78 | 100 | 48 | 16 | 273 | |
| Gary Nicolin | 127 | 56 | 94 | 173 | 9 | 270 | |
| Jean Caron | 105 | 37 | 128 | 42 | 12 | 281 | |
| Kengo Ogura | 138 | 126 | 70 | 24 | 20 | 221 |
All Works
Loading papers...